Quantification of the pro-form of human complement component factor D (adipsin).


Journal

Journal of immunological methods
ISSN: 1872-7905
Titre abrégé: J Immunol Methods
Pays: Netherlands
ID NLM: 1305440

Informations de publication

Date de publication:
08 2022
Historique:
received: 29 03 2022
revised: 31 05 2022
accepted: 01 06 2022
pubmed: 10 6 2022
medline: 15 7 2022
entrez: 9 6 2022
Statut: ppublish

Résumé

Factor D (also known as adipsin) is a serine protease and part of the complement system, involved in innate immune responses and effector functions of antibodies. Factor D cleaves factor B complexed with C3b, leading to the C3 convertase C3bBb. This C3 convertase is central in the alternative activation pathway and the amplification loop, which amplifies the two other complement activation pathways: the classical pathway and the lectin pathway. Adipocytes synthesize factor D as a pro-form comprising 6 additional residues that must be cleaved off to generate a mature form. The MBL-associated serine protease 3 (MASP-3), found in complex with the pattern recognition molecules of lectin activation pathway, converts the pro-form to mature factor D, which reportedly is the most abundant form found in the circulation at concentrations of 1-2 μg/ml among healthy individuals. The mature factor D is rate-limiting for complement activation, but little is known about the distribution of pro vs. mature factor D in the circulation, the regulation hereof and the potential activation stimuli of the lectin pathway, responsible for activation of MASP-3 and subsequent conversion of pro-form of factor D. In this light we established and validated an ELISA specific for measuring the pro-form of complement factor D. With a working range of 0.82-25 ng/ml, acceptable intra and inter assay CVs, and a relative recovery rate above 90%, we found that the median plasma concentration in Danish blood donors was 134 ng/ml; corresponding to that 8-15% factor D circulates as pro-form. We also found that blood sampling procedures affect conversion and hence the levels measured in serum and plasma.

Identifiants

pubmed: 35679953
pii: S0022-1759(22)00082-5
doi: 10.1016/j.jim.2022.113295
pii:
doi:

Substances chimiques

Lectins 0
Complement C3-C5 Convertases EC 3.4.21.-
Mannose-Binding Protein-Associated Serine Proteases EC 3.4.21.-
Complement Factor D EC 3.4.21.46

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113295

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Maiken Lumby Henriksen (ML)

Dept. of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.

Christian Nielsen (C)

Dept. of Clinical Immunology, Odense University Hospital, Odense, Denmark.

Dennis Pedersen (D)

Dept. of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

Gregers Rom Andersen (GR)

Dept. of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

Steffen Thiel (S)

Dept. of Biomedicine, Aarhus University, Aarhus, Denmark.

Yaseelan Palarasah (Y)

Dept. of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.

Soren Werner Karlskov Hansen (SWK)

Dept. of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark. Electronic address: shansen@health.sdu.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH